To Enrich One's Life, To Make One Beautiful
Enrich life and make people beautiful
with convergence technology
About Apimeds
Apimeds opens up a harmonious future in various fields of business.
Business Field
Apimeds opens up a harmonious future in various fields of business.
Bio Business
We will become a leading company in the bio industry based on our core technology.
SmartGrid Business
With the globalization of Korean PLC, we will take the lead in implementing smart grid systems.
MVNO Business
Provide differentiated services through communication with customers.
Distribution Business
We will make the world shine even more.
Investor Relations
Inscobee leaps forward as a leader in future social change.
About Apimeds
Apimeds opens up a harmonious future in various fields of business.
About INSCOBEE
Inscobee opens up a harmonious future in various fields of business.
To Enrich One's Life, To Make One Beautiful
Enrich life and make people beautiful
with convergence technology
Main field of business
Apimeds, Inc. is leading the discovery of new growth engines in various fields of business,Bio
Apitoxin is made by extraction of Apis Mellifera by special facilities and methods and apitoxin is the only prescription drug that has been approved by the Ministry of Food and Drug Safety in Korea.
Main field of business
Inscobee, Inc. is leading the discovery of new growth engines in various fields of business,Smart Grid business
Main field of business
Inscobee, Inc. is leading the discovery of new growth engines in various fields of business,Communication business
We use the networks of three domestic mobile carriers (SKT, KT, LGU+) to provide MVNO service.
With MVNO, we will realise the burdenless communication service customers want.
Main field of business
Inscobee, Inc. is leading the discovery of new growth engines in various fields of business,Distribution business
Inscobee is constantly striving for change and innovation in the distribution industry.
We will distribute various products through innovation and diversification of distribution channels and continue to pioneer new fields.
Apimeds in numbers
2003
Date of incorporation
2007
Japanese patent
2013
US Patent
2020
Research Institute